Orchid Pharma Ltd (ORCHPHARMA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 653435, "name": "Orchid Pharma", "stock_name": "Orchid Pharma", "full_name": "Orchid Pharma Ltd", "name_url": "stocks-analysis/orchid-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "704.10", "chg": 22.7, "chgp": "3.33%", "dir": 1, "prev_price": "681.40", "mcapval": "3,449.00 Cr", "mcap": "Small Cap", "scripcode": 524372, "symbol": "ORCHPHARMA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE191A01027", "curr_date": "May 08", "curr_time": "", "bse_nse_vol": "90.92 k", "exc_status": "Active", "traded_date": "May 08, 2026", "traded_date_str": "2026 05 08", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/orchid-pharma-653435-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Orchid Pharma Ltd Valuation Shifts Signal Heightened Price Risk Amid Sector Comparisons", "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-valuation-shifts-signal-heightened-price-risk-amid-sector-comparisons-3978697", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/OrchidPharmaLtd_valuationdot_3978697.png", "date": "2026-05-07 08:01:22", "description": "Orchid Pharma Ltd has witnessed a significant shift in its valuation parameters, moving from an expensive to a very expensive rating, driven primarily by a sharp rise in its price-to-earnings (P/E) ratio to 129.78. Despite this valuation surge, the company’s recent returns have been mixed, with strong short-term gains contrasting with underperformance over longer horizons relative to the Sensex." }, { "title": "Orchid Pharma Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/orchid-pharma-ltd-is-rated-strong-sell-3972139", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/OrchidPharmaLtd_mojoScore_3972139.png", "date": "2026-05-01 10:10:17", "description": "Orchid Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Orchid Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-3965574", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/OrchidPharmaLtd_technicaldot_3965574.png", "date": "2026-04-28 08:03:21", "description": "Orchid Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in price momentum and technical indicators, reflecting a complex market sentiment. Despite a recent day gain of 3.39%, the stock remains under pressure with a strong sell rating and mixed signals from key technical tools such as MACD, RSI, and moving averages." }, { "title": "Orchid Pharma Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/orchid-pharma-ltd-is-rated-strong-sell-3953858", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/OrchidPharmaLtd_mojoScore_3953858.png", "date": "2026-04-20 10:10:26", "description": "Orchid Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 February 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below are based on the company’s current position as of 20 April 2026, providing investors with the latest insights into its performance and valuation." }, { "title": "Orchid Pharma Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/orchid-pharma-ltd-is-rated-strong-sell-3939445", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/OrchidPharmaLtd_mojoScore_3939445.png", "date": "2026-04-09 10:10:18", "description": "Orchid Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Feb 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 09 April 2026, providing investors with the latest insights into its performance and valuation." }, { "title": "Orchid Pharma Ltd Opens 8.42% Higher in Sharp Gap Up, But Can the Technicals Support It?", "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-opens-strong-with-significant-gap-up-on-842-gain-3937188", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/OrchidPharmaLtd_gapup_3937188.png", "date": "2026-04-08 09:50:21", "description": "" }, { "title": "Orchid Pharma Gains 3.70%: Key Market Moves and Technical Signals This Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-gains-370-key-market-moves-and-technical-signals-this-week-3932165", "imagepath": "", "date": "2026-04-04 16:05:19", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>30 Mar:</strong> New 52-week low at Rs.478.35 amid market weakness</p>\n <p><strong>1 Apr:</strong> Intraday high surge of 7.21%, closing at Rs.517.00</p>\n <p><strong>2 Apr:</strong> Moderate gain of 0.99%, closing at Rs.522.10</p>\n <p><strong>3 Apr:</strong> No trading data available</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.503.45</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.522.10</div><div class=\"stat-change posit..." }, { "title": "Orchid Pharma Ltd Surges 7.21% to Day's High of Rs 499 — Outperforms Sector by 1.52 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-hits-intraday-high-with-721-surge-on-1-april-2026-3927811", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/OrchidPharmaLtd_priceRelatedfactors_3927811.png", "date": "2026-04-01 09:32:08", "description": "The Sensex gained 2.7% on 1 Apr 2026, yet Orchid Pharma Ltd outpaced the broader market with a 7.21% intraday rally, reaching a high of Rs 499. This 1.52 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific surge rather than a market-wide lift." }, { "title": "Markets Rally, But Orchid Pharma Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off", "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-stock-falls-to-52-week-low-of-rs483-3924456", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/OrchidPharmaLtd_priceRelatedfactors_3924456.png", "date": "2026-03-30 11:17:38", "description": "Despite a broader market rebound, Orchid Pharma Ltd has succumbed to renewed selling pressure, hitting a fresh 52-week low of Rs 483 on 30 Mar 2026. This decline extends a recent losing streak that has dragged the stock down by 6.85% over two sessions, underscoring persistent headwinds for the small-cap pharmaceutical player." } ], "total": 321, "sid": "653435", "stock_news_url": "https://www.marketsmojo.com/news/orchid-pharma-653435" }, "announcements": [ { "caption": "Intimation Under Regulation 30", "datetime": "11-Apr-2026", "details": "Intimation under Regulation 30 of SEBI (LODR) Regulations 2015.", "source": "BSE" }, { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "09-Apr-2026", "details": "Confirmation certificate under Regulation 74(5) of SEBI (Depositories and participants) Regulations 2018 for the Quarter- IV ended on March 31 2026 of FY 2025-26.", "source": "BSE" }, { "caption": "Investor Roadshow Scheduled To Be Held On April 10 2026.", "datetime": "07-Apr-2026", "details": "Intimation of Roadshow scheduled to be held on April 10 2026.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Orchid Pharma Ltd has declared <strong>30%</strong> dividend, ex-date: 13 Sep 12", "dt": "2012-09-13", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

30 Mar: New 52-week low at Rs.478.35 amid market weakness

1 Apr: Intraday high surge of 7.21%, closing at Rs.517.00

2 Apr: Moderate gain of 0.99%, closing at Rs.522.10

3 Apr: No trading data available

Read full news article

Orchid Pharma Ltd Surges 7.21% to Day's High of Rs 499 — Outperforms Sector by 1.52 Percentage Points

2026-04-01 09:32:08

The Sensex gained 2.7% on 1 Apr 2026, yet Orchid Pharma Ltd outpaced the broader market with a 7.21% intraday rally, reaching a high of Rs 499. This 1.52 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific surge rather than a market-wide lift.

Read full news article

Markets Rally, But Orchid Pharma Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-30 11:17:38

Despite a broader market rebound, Orchid Pharma Ltd has succumbed to renewed selling pressure, hitting a fresh 52-week low of Rs 483 on 30 Mar 2026. This decline extends a recent losing streak that has dragged the stock down by 6.85% over two sessions, underscoring persistent headwinds for the small-cap pharmaceutical player.

Read full news article